(Reuters) – The European Union’s drug regulator on Thursday approved a hike in manufacturing capacity for COVID-19 vaccines from Janssen, Moderna and BioNTech/Pfizer as Europe gears up for the fight against the Omicron variant.
(Reporting by Aby Jose Koilparambil in Bengaluru; Editing by Shounak Dasgupta)
